Literature DB >> 27695256

Future in neuromedicine: Nanotechnology.

Adrija Hajra1, Dhrubajyoti Bandyopadhyay2, Shyamal Kumar Hajra3.   

Abstract

Entities:  

Year:  2016        PMID: 27695256      PMCID: PMC5006488          DOI: 10.4103/0976-3147.185513

Source DB:  PubMed          Journal:  J Neurosci Rural Pract        ISSN: 0976-3155


× No keyword cloud information.
Sir, The concept of nanomedicine is a new and exciting topic. Its application in neurology is a promising field for research. Use of nanoparticles in neuromedicine undoubtedly will open up a new horizon. The aim of this letter is to highlight some recent data about the use of nanotechnology in neuromedicine. Recently, an animal study has shown an encouraging result in multiple sclerosis as well as autoimmune encephalitis by administration of nanodroplet formulation of pomegranate seed oil.[1] In the case of refractory epilepsy, optimum drug delivery to the brain is an ongoing battle. Tryptophan-derived nanoparticles showed promising outcome in drug delivery in refractory seizure disorder patients.[2] Nanoparticles are postulated to target myeloid cells in epileptogenic brain tissue of rats. Presurgical and intrasurgical localization of epileptic foci can be done by these particles. This technique will be helpful for future treatment of epilepsy.[3] Multimer detection system causes differentiation of prion multimers through their multimeric expression of epitopes. Probably, it is going to be a great achievement to diagnose prion-associated diseases using nanotechnology.[4] New nanoparticles have been found that can enable remote-controlled magnetic guiding for stem cell homing. The method may result in positive end point for treatment of many diseases including stroke.[5] The existence of the blood-brain barrier causes hindrance for targeted drug delivery within brain tissue. “Autocatalytic” approach has been proposed to combat this problem. Few nanoparticles enter into the brain through the process of transcytosis or the gaps in blood brain barrier. The nanoparticles release some blood brain barrier modulators, which results in more nanoparticles entry. This technique has a potential role in treatment as well as imaging of brain tumor.[6] Recently, nanoparticles help increase the permeability of blood brain barrier by proper delivery of lexiscan to central nervous system. The technique autocatalytically augments the targeting delivery of chlorotoxin-anchored nanoparticles. Nogo-66 receptor antagonist peptide NEP1-40 loaded nanoparticles have been shown to cause reduction of infarct volume.[7] Hence, these nanotechnologies will reduce the problem of drug delivery due to the blood-brain barrier. In the case of neurodegenerative disorders also improved drug delivery will bring a significant improvement in the disease course.[8] Gadolinium-based nanoparticles in combination with radiation therapy showed increased tumor cells death in animals with multiple brain melanoma metastasis.[9] It is interesting that nanotechnology is emerging as a promising modality for the treatment of brain cancer. Iron nanoparticles are used for labeling human neural stem cells. This technique will help track the localization as well as the survival of the stem cells. In patients with Parkinson's disease, magnetic resonance imaging (MRI) will detect these labeled stem cells, and it will be helpful for follow-up of the patient.[10] Another interesting use of iron nanoparticles is to deliver anti interleukin-1β to the epileptogenic focus in the temporal lobe. This technique will be helpful for MRI diagnosis and therapy of epilepsy.[11] Carbon nanowires and nanotubes are being tried to use in neural repair and regeneration. They have an influence on cellular signal transmission. They are showing promising results in: Neural regeneration and repair Repair of stroke damage Treatment of cancer and brain tumors Improvement of cerebrovascular dysfunction after brain trauma For diagnosis as well as treatment of primary brain tumors Augmentation of neural cell function within the brain.[12] Naturally, it is evident that application of nanotechnology will be a great achievement in the field of neurology. It will help diagnose as well as treat many neurologic conditions. We will wait to enlighten ourselves with further knowledge about this in future.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  12 in total

1.  Multitheragnostic Multi-GNRs Crystal-Seeded Magnetic Nanoseaurchin for Enhanced In Vivo Mesenchymal-Stem-Cell Homing, Multimodal Imaging, and Stroke Therapy.

Authors:  Po-Jung Chen; Yi-Da Kang; Chen-Huan Lin; San-Yuan Chen; Chia-Hung Hsieh; You-Yin Chen; Chun-Wei Chiang; Wei Lee; Chung-Y Hsu; Lun-De Liao; Chih-Tai Fan; Meng-Lin Li; Woei-Cherng Shyu
Journal:  Adv Mater       Date:  2015-09-25       Impact factor: 30.849

2.  Tracking inflammation in the epileptic rat brain by bi-functional fluorescent and magnetic nanoparticles.

Authors:  Emma Portnoy; Boris Polyak; Dorrit Inbar; Gilad Kenan; Ahmad Rai; Suzanne L Wehrli; Timothy P L Roberts; Ameer Bishara; Aniv Mann; Miriam Shmuel; Katya Rozovsky; Gal Itzhak; Tamir Ben-Hur; Shlomo Magdassi; Dana Ekstein; Sara Eyal
Journal:  Nanomedicine       Date:  2016-03-07       Impact factor: 5.307

3.  Increased Nanoparticle Delivery to Brain Tumors by Autocatalytic Priming for Improved Treatment and Imaging.

Authors:  Liang Han; Derek K Kong; Ming-Qiang Zheng; Sasidhar Murikinati; Chao Ma; Peng Yuan; Liyuan Li; Daofeng Tian; Qiang Cai; Chunlin Ye; Daniel Holden; June-Hee Park; Xiaobin Gao; Jean-Leon Thomas; Jaime Grutzendler; Richard E Carson; Yiyun Huang; Joseph M Piepmeier; Jiangbing Zhou
Journal:  ACS Nano       Date:  2016-03-16       Impact factor: 15.881

Review 4.  Improving drug delivery technology for treating neurodegenerative diseases.

Authors:  Yahya E Choonara; Pradeep Kumar; Girish Modi; Viness Pillay
Journal:  Expert Opin Drug Deliv       Date:  2016-03-24       Impact factor: 6.648

5.  Targeted drug delivery to ischemic stroke via chlorotoxin-anchored, lexiscan-loaded nanoparticles.

Authors:  Liang Han; Qiang Cai; Daofeng Tian; Derek K Kong; Xingchun Gou; Zeming Chen; Stephen M Strittmatter; Zuoheng Wang; Kevin N Sheth; Jiangbing Zhou
Journal:  Nanomedicine       Date:  2016-03-30       Impact factor: 5.307

6.  Functionalized nanocarrier combined seizure-specific vector with P-glycoprotein modulation property for antiepileptic drug delivery.

Authors:  Jiansheng Liu; Yajing He; Jun Zhang; Jiajia Li; Xiangrong Yu; Zhonglian Cao; Fanmin Meng; Yuwu Zhao; Xunyi Wu; Teng Shen; Zhen Hong
Journal:  Biomaterials       Date:  2015-09-30       Impact factor: 12.479

7.  Gadolinium-Based Nanoparticles and Radiation Therapy for Multiple Brain Melanoma Metastases: Proof of Concept before Phase I Trial.

Authors:  Shady Kotb; Alexandre Detappe; François Lux; Florence Appaix; Emmanuel L Barbier; Vu-Long Tran; Marie Plissonneau; Hélène Gehan; Florence Lefranc; Claire Rodriguez-Lafrasse; Camille Verry; Ross Berbeco; Olivier Tillement; Lucie Sancey
Journal:  Theranostics       Date:  2016-01-20       Impact factor: 11.556

8.  Value of Functionalized Superparamagnetic Iron Oxide Nanoparticles in the Diagnosis and Treatment of Acute Temporal Lobe Epilepsy on MRI.

Authors:  Tingting Fu; Qingxia Kong; Huaqiang Sheng; Lingyun Gao
Journal:  Neural Plast       Date:  2016-01-27       Impact factor: 3.599

9.  Treatment of a multiple sclerosis animal model by a novel nanodrop formulation of a natural antioxidant.

Authors:  Orli Binyamin; Liraz Larush; Kati Frid; Guy Keller; Yael Friedman-Levi; Haim Ovadia; Oded Abramsky; Shlomo Magdassi; Ruth Gabizon
Journal:  Int J Nanomedicine       Date:  2015-11-20

Review 10.  Nanostructures: a platform for brain repair and augmentation.

Authors:  Ruxandra Vidu; Masoud Rahman; Morteza Mahmoudi; Marius Enachescu; Teodor D Poteca; Ioan Opris
Journal:  Front Syst Neurosci       Date:  2014-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.